Zoledronic acid, sold in the U.S. by Novartis under the brand name Reclast, just received final approval from the FDA for the treatment of osteoporosis. The bisphosphonate medication is taken intravenously once a year and has been on the market to treat other bone diseases. Its approval f...


Thanks for writing, Lila.
Here's a previous SharePost from Lila also regarding the drug Reclast:
Once-a-Year Osteoporosis Medicine
http://www.healthcentral.com/osteoporosis/c/9487/9180/medicine/
For readers interested in more information about drugs prescribed for osteoporosis, see:
Osteoporosis Medications
http://www.healthcentral.com/osteoporosis/treatment-000018_8-145.html
Best,
Maria
Maria Gifford
Community Moderator
OsteoporosisConnection.com